NO312065B1 - Benzosulfon-derivater, anvendelse og fremgangsmåte for fremstilling derav, samt medikament - Google Patents
Benzosulfon-derivater, anvendelse og fremgangsmåte for fremstilling derav, samt medikament Download PDFInfo
- Publication number
- NO312065B1 NO312065B1 NO19990187A NO990187A NO312065B1 NO 312065 B1 NO312065 B1 NO 312065B1 NO 19990187 A NO19990187 A NO 19990187A NO 990187 A NO990187 A NO 990187A NO 312065 B1 NO312065 B1 NO 312065B1
- Authority
- NO
- Norway
- Prior art keywords
- amino
- sulfonyl
- benzenesulfonyl
- phenylamine
- mol
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 16
- 239000003814 drug Substances 0.000 title claims description 11
- 229940079593 drug Drugs 0.000 title claims description 7
- 238000002360 preparation method Methods 0.000 title claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 54
- -1 t-butylethynyl Chemical group 0.000 claims description 30
- 229910052739 hydrogen Inorganic materials 0.000 claims description 22
- 239000001257 hydrogen Substances 0.000 claims description 22
- WDFMDNUTOSLOPW-UHFFFAOYSA-N 4-(2-bromo-6-pyrrolidin-1-ylpyridin-4-yl)sulfonylaniline Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC(Br)=NC(N2CCCC2)=C1 WDFMDNUTOSLOPW-UHFFFAOYSA-N 0.000 claims description 21
- 150000003839 salts Chemical class 0.000 claims description 17
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 16
- 125000003282 alkyl amino group Chemical group 0.000 claims description 15
- 125000000217 alkyl group Chemical group 0.000 claims description 15
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 10
- 125000003277 amino group Chemical group 0.000 claims description 7
- 229910052736 halogen Inorganic materials 0.000 claims description 7
- 150000002367 halogens Chemical class 0.000 claims description 7
- 125000006239 protecting group Chemical group 0.000 claims description 7
- 125000006701 (C1-C7) alkyl group Chemical group 0.000 claims description 6
- 208000024827 Alzheimer disease Diseases 0.000 claims description 6
- 208000020925 Bipolar disease Diseases 0.000 claims description 6
- 208000023105 Huntington disease Diseases 0.000 claims description 6
- 208000026139 Memory disease Diseases 0.000 claims description 6
- 208000012902 Nervous system disease Diseases 0.000 claims description 6
- 208000025966 Neurological disease Diseases 0.000 claims description 6
- 208000018737 Parkinson disease Diseases 0.000 claims description 6
- 208000028017 Psychotic disease Diseases 0.000 claims description 6
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 6
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 6
- 201000000980 schizophrenia Diseases 0.000 claims description 6
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 6
- KKDCGGDVDFZYTB-UHFFFAOYSA-N 4-(2-chloro-6-pyrrolidin-1-ylpyridin-4-yl)sulfonylaniline Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC(Cl)=NC(N2CCCC2)=C1 KKDCGGDVDFZYTB-UHFFFAOYSA-N 0.000 claims description 5
- 125000003545 alkoxy group Chemical group 0.000 claims description 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 5
- 230000002265 prevention Effects 0.000 claims description 5
- LFHKWOGVMDGOGO-UHFFFAOYSA-N 1-[6-bromo-4-[3-(trifluoromethyl)phenyl]sulfonylpyridin-2-yl]piperazine Chemical compound FC(F)(F)C1=CC=CC(S(=O)(=O)C=2C=C(N=C(Br)C=2)N2CCNCC2)=C1 LFHKWOGVMDGOGO-UHFFFAOYSA-N 0.000 claims description 4
- SGVIRQMTPUPXBQ-UHFFFAOYSA-N 2-(4-aminophenyl)sulfonyl-6-bromo-n-methylpyridin-4-amine Chemical compound CNC1=CC(Br)=NC(S(=O)(=O)C=2C=CC(N)=CC=2)=C1 SGVIRQMTPUPXBQ-UHFFFAOYSA-N 0.000 claims description 4
- OEQIXIYYFHPIAA-UHFFFAOYSA-N 4-(2-iodo-6-pyrrolidin-1-ylpyridin-4-yl)sulfonylaniline Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC(I)=NC(N2CCCC2)=C1 OEQIXIYYFHPIAA-UHFFFAOYSA-N 0.000 claims description 4
- GTTIHTACBBSWCF-UHFFFAOYSA-N 4-(2-phenyl-6-pyrrolidin-1-ylpyridin-4-yl)sulfonylaniline Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC(N2CCCC2)=NC(C=2C=CC=CC=2)=C1 GTTIHTACBBSWCF-UHFFFAOYSA-N 0.000 claims description 4
- KSABNQBKVGBSGB-UHFFFAOYSA-N 4-(4-aminophenyl)sulfonyl-6-bromo-n,n-dimethylpyridin-2-amine Chemical compound BrC1=NC(N(C)C)=CC(S(=O)(=O)C=2C=CC(N)=CC=2)=C1 KSABNQBKVGBSGB-UHFFFAOYSA-N 0.000 claims description 4
- IXNHUQDFMNQLLU-UHFFFAOYSA-N 4-(4-aminophenyl)sulfonyl-6-bromo-n-methylpyrimidin-2-amine Chemical compound CNC1=NC(Br)=CC(S(=O)(=O)C=2C=CC(N)=CC=2)=N1 IXNHUQDFMNQLLU-UHFFFAOYSA-N 0.000 claims description 4
- 125000000392 cycloalkenyl group Chemical group 0.000 claims description 4
- 150000002431 hydrogen Chemical class 0.000 claims description 4
- 125000002757 morpholinyl group Chemical group 0.000 claims description 4
- NBKOKAWBESVBAX-UHFFFAOYSA-N n'-[4-(4-aminophenyl)sulfonyl-6-bromopyridin-2-yl]butane-1,4-diamine Chemical compound BrC1=NC(NCCCCN)=CC(S(=O)(=O)C=2C=CC(N)=CC=2)=C1 NBKOKAWBESVBAX-UHFFFAOYSA-N 0.000 claims description 4
- 125000004193 piperazinyl group Chemical group 0.000 claims description 4
- 125000000719 pyrrolidinyl group Chemical group 0.000 claims description 4
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 claims description 4
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims description 4
- 229920002554 vinyl polymer Polymers 0.000 claims description 4
- YRYVAGQJEFNFOP-UHFFFAOYSA-N 3-(4-aminophenyl)sulfonyl-5-bromo-n,n-dimethylaniline Chemical compound CN(C)C1=CC(Br)=CC(S(=O)(=O)C=2C=CC(N)=CC=2)=C1 YRYVAGQJEFNFOP-UHFFFAOYSA-N 0.000 claims description 3
- FGDYWIYXFCDHOI-UHFFFAOYSA-N 3-[3-(4-aminophenyl)sulfonyl-5-bromoanilino]propan-1-ol Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC(Br)=CC(NCCCO)=C1 FGDYWIYXFCDHOI-UHFFFAOYSA-N 0.000 claims description 3
- KSMWSYNAJGWNMR-UHFFFAOYSA-N 4-(2-bromo-6-piperazin-1-ylpyridin-4-yl)sulfonylaniline Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC(Br)=NC(N2CCNCC2)=C1 KSMWSYNAJGWNMR-UHFFFAOYSA-N 0.000 claims description 3
- 208000020401 Depressive disease Diseases 0.000 claims description 3
- 239000002253 acid Substances 0.000 claims description 3
- 230000029936 alkylation Effects 0.000 claims description 3
- 238000005804 alkylation reaction Methods 0.000 claims description 3
- GFEVWNLYXLPKDQ-UHFFFAOYSA-N n-[4-(4-aminophenyl)sulfonyl-6-bromopyridin-2-yl]-n',n'-diethylpropane-1,3-diamine Chemical compound BrC1=NC(NCCCN(CC)CC)=CC(S(=O)(=O)C=2C=CC(N)=CC=2)=C1 GFEVWNLYXLPKDQ-UHFFFAOYSA-N 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 3
- 230000003647 oxidation Effects 0.000 claims description 3
- 238000007254 oxidation reaction Methods 0.000 claims description 3
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 2
- SRJVAKMYNBMXLD-UHFFFAOYSA-N 3-(4-aminophenyl)sulfonyl-5-bromo-n-methylaniline Chemical compound CNC1=CC(Br)=CC(S(=O)(=O)C=2C=CC(N)=CC=2)=C1 SRJVAKMYNBMXLD-UHFFFAOYSA-N 0.000 claims description 2
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims description 2
- 125000002648 azanetriyl group Chemical group *N(*)* 0.000 claims description 2
- 208000028683 bipolar I disease Diseases 0.000 claims description 2
- ZPGINSOGHDYPOS-UHFFFAOYSA-N n'-[3-(4-aminophenyl)sulfonyl-5-bromophenyl]-n-methylpropane-1,3-diamine Chemical compound CNCCCNC1=CC(Br)=CC(S(=O)(=O)C=2C=CC(N)=CC=2)=C1 ZPGINSOGHDYPOS-UHFFFAOYSA-N 0.000 claims description 2
- RXRLZOAYLADWKH-UHFFFAOYSA-N n-[4-(4-aminophenyl)sulfonyl-6-bromopyridin-2-yl]-n',n'-dimethylethane-1,2-diamine Chemical compound BrC1=NC(NCCN(C)C)=CC(S(=O)(=O)C=2C=CC(N)=CC=2)=C1 RXRLZOAYLADWKH-UHFFFAOYSA-N 0.000 claims description 2
- 150000002828 nitro derivatives Chemical class 0.000 claims description 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 2
- 125000004076 pyridyl group Chemical group 0.000 claims description 2
- 125000004527 pyrimidin-4-yl group Chemical group N1=CN=C(C=C1)* 0.000 claims description 2
- 125000000714 pyrimidinyl group Chemical group 0.000 claims description 2
- 125000001424 substituent group Chemical group 0.000 claims description 2
- VQGXDKWYDBXYNK-UHFFFAOYSA-N 4-(4-aminophenyl)sulfonyl-6-bromo-n-methylpyridin-2-amine Chemical compound BrC1=NC(NC)=CC(S(=O)(=O)C=2C=CC(N)=CC=2)=C1 VQGXDKWYDBXYNK-UHFFFAOYSA-N 0.000 claims 2
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 1
- 230000004048 modification Effects 0.000 claims 1
- 238000012986 modification Methods 0.000 claims 1
- VFGHVHYBFRCHNM-UHFFFAOYSA-N n-[4-(4-aminophenyl)sulfonyl-6-bromopyridin-2-yl]-n',n'-dimethylpropane-1,3-diamine Chemical compound BrC1=NC(NCCCN(C)C)=CC(S(=O)(=O)C=2C=CC(N)=CC=2)=C1 VFGHVHYBFRCHNM-UHFFFAOYSA-N 0.000 claims 1
- 125000001624 naphthyl group Chemical group 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 388
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 198
- 239000002904 solvent Substances 0.000 description 123
- 239000000243 solution Substances 0.000 description 111
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 108
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 104
- 239000000203 mixture Substances 0.000 description 103
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 97
- 239000000741 silica gel Substances 0.000 description 96
- 229910002027 silica gel Inorganic materials 0.000 description 96
- WDYVUKGVKRZQNM-UHFFFAOYSA-N 6-phosphonohexylphosphonic acid Chemical compound OP(O)(=O)CCCCCCP(O)(O)=O WDYVUKGVKRZQNM-UHFFFAOYSA-N 0.000 description 82
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 75
- 239000013078 crystal Substances 0.000 description 69
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 60
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 60
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 54
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 46
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 44
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 42
- 239000012074 organic phase Substances 0.000 description 40
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 39
- 239000007787 solid Substances 0.000 description 38
- 239000011541 reaction mixture Substances 0.000 description 30
- 238000001914 filtration Methods 0.000 description 29
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 24
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 21
- 235000019341 magnesium sulphate Nutrition 0.000 description 21
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 20
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 20
- HEMHJVSKTPXQMS-UHFFFAOYSA-M sodium hydroxide Inorganic materials [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 20
- YNHIGQDRGKUECZ-UHFFFAOYSA-L bis(triphenylphosphine)palladium(ii) dichloride Chemical compound [Cl-].[Cl-].[Pd+2].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 YNHIGQDRGKUECZ-UHFFFAOYSA-L 0.000 description 19
- 229920006395 saturated elastomer Polymers 0.000 description 19
- 238000003818 flash chromatography Methods 0.000 description 18
- 239000000706 filtrate Substances 0.000 description 17
- 238000010992 reflux Methods 0.000 description 17
- 238000001035 drying Methods 0.000 description 16
- NHQDETIJWKXCTC-UHFFFAOYSA-N 3-chloroperbenzoic acid Chemical compound OOC(=O)C1=CC=CC(Cl)=C1 NHQDETIJWKXCTC-UHFFFAOYSA-N 0.000 description 15
- VVFLAMYJXXXEAN-UHFFFAOYSA-N 4-(2,6-dibromopyridin-4-yl)sulfonylaniline Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC(Br)=NC(Br)=C1 VVFLAMYJXXXEAN-UHFFFAOYSA-N 0.000 description 15
- LULAYUGMBFYYEX-UHFFFAOYSA-N metachloroperbenzoic acid Natural products OC(=O)C1=CC=CC(Cl)=C1 LULAYUGMBFYYEX-UHFFFAOYSA-N 0.000 description 15
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 13
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 13
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 12
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 12
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 12
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 11
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 11
- 239000003921 oil Substances 0.000 description 11
- 235000019198 oils Nutrition 0.000 description 11
- 239000011734 sodium Substances 0.000 description 11
- 229910000027 potassium carbonate Inorganic materials 0.000 description 10
- 239000000843 powder Substances 0.000 description 10
- 239000000047 product Substances 0.000 description 10
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N tetrahydrofuran Substances C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 9
- XIPATZUHJFQGQC-UHFFFAOYSA-N 2,6-dibromo-4-nitropyridine Chemical compound [O-][N+](=O)C1=CC(Br)=NC(Br)=C1 XIPATZUHJFQGQC-UHFFFAOYSA-N 0.000 description 8
- 238000000354 decomposition reaction Methods 0.000 description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N pyridine Substances C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 7
- 229960000583 acetic acid Drugs 0.000 description 7
- 239000000969 carrier Substances 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 239000002002 slurry Substances 0.000 description 7
- 239000000725 suspension Substances 0.000 description 7
- 108091005435 5-HT6 receptors Proteins 0.000 description 6
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 6
- 239000012267 brine Substances 0.000 description 6
- 238000004587 chromatography analysis Methods 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 239000003960 organic solvent Substances 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 235000017550 sodium carbonate Nutrition 0.000 description 6
- 229910000029 sodium carbonate Inorganic materials 0.000 description 6
- 229940001593 sodium carbonate Drugs 0.000 description 6
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 6
- AQZYJKWPVAMDSM-UHFFFAOYSA-N 2,6-dibromo-4-(4-nitrophenyl)sulfanylpyridine Chemical compound C1=CC([N+](=O)[O-])=CC=C1SC1=CC(Br)=NC(Br)=C1 AQZYJKWPVAMDSM-UHFFFAOYSA-N 0.000 description 5
- HCQLFCIOSVENRN-UHFFFAOYSA-N 2,6-dibromo-4-(4-nitrophenyl)sulfonylpyridine Chemical compound C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)C1=CC(Br)=NC(Br)=C1 HCQLFCIOSVENRN-UHFFFAOYSA-N 0.000 description 5
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 5
- 239000012298 atmosphere Substances 0.000 description 5
- BOZXAECLDPEYGE-UHFFFAOYSA-N 2,6-dibromo-4-[3-(trifluoromethyl)phenyl]sulfonylpyridine Chemical compound FC(F)(F)C1=CC=CC(S(=O)(=O)C=2C=C(Br)N=C(Br)C=2)=C1 BOZXAECLDPEYGE-UHFFFAOYSA-N 0.000 description 4
- LGRFBXHJZUNVBU-UHFFFAOYSA-N 4-(2-bromo-6-methylpyridin-4-yl)sulfonylaniline Chemical compound BrC1=NC(C)=CC(S(=O)(=O)C=2C=CC(N)=CC=2)=C1 LGRFBXHJZUNVBU-UHFFFAOYSA-N 0.000 description 4
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 4
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 4
- 102100026459 POU domain, class 3, transcription factor 2 Human genes 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 4
- WUGQZFFCHPXWKQ-UHFFFAOYSA-N Propanolamine Chemical compound NCCCO WUGQZFFCHPXWKQ-UHFFFAOYSA-N 0.000 description 4
- 229910004298 SiO 2 Inorganic materials 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 4
- 239000003054 catalyst Substances 0.000 description 4
- 230000003197 catalytic effect Effects 0.000 description 4
- 229910052681 coesite Inorganic materials 0.000 description 4
- 229910052906 cristobalite Inorganic materials 0.000 description 4
- 238000002330 electrospray ionisation mass spectrometry Methods 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 239000007903 gelatin capsule Substances 0.000 description 4
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 4
- IFYDWYVPVAMGRO-UHFFFAOYSA-N n-[3-(dimethylamino)propyl]tetradecanamide Chemical compound CCCCCCCCCCCCCC(=O)NCCCN(C)C IFYDWYVPVAMGRO-UHFFFAOYSA-N 0.000 description 4
- 239000000825 pharmaceutical preparation Substances 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- 235000012239 silicon dioxide Nutrition 0.000 description 4
- 229910052682 stishovite Inorganic materials 0.000 description 4
- 108010072897 transcription factor Brn-2 Proteins 0.000 description 4
- 229910052905 tridymite Inorganic materials 0.000 description 4
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 3
- XEPRUPUTKJOFNO-UHFFFAOYSA-N 2-bromo-4-nitro-6-(4-nitrophenyl)sulfonylpyridine Chemical compound C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)C1=CC([N+]([O-])=O)=CC(Br)=N1 XEPRUPUTKJOFNO-UHFFFAOYSA-N 0.000 description 3
- OKZLYPGUZPTKSA-UHFFFAOYSA-N 3-bromo-n-methyl-5-(4-nitrophenyl)sulfanylaniline Chemical compound CNC1=CC(Br)=CC(SC=2C=CC(=CC=2)[N+]([O-])=O)=C1 OKZLYPGUZPTKSA-UHFFFAOYSA-N 0.000 description 3
- WRLXFBBQMOJTMH-UHFFFAOYSA-N 4-(2-ethenyl-6-pyrrolidin-1-ylpyridin-4-yl)sulfonylaniline Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC(C=C)=NC(N2CCCC2)=C1 WRLXFBBQMOJTMH-UHFFFAOYSA-N 0.000 description 3
- QQWXKOSSNKTSMP-UHFFFAOYSA-N 4-(2-prop-1-en-2-yl-6-pyrrolidin-1-ylpyridin-4-yl)sulfonylaniline Chemical compound N=1C(C(=C)C)=CC(S(=O)(=O)C=2C=CC(N)=CC=2)=CC=1N1CCCC1 QQWXKOSSNKTSMP-UHFFFAOYSA-N 0.000 description 3
- SBIYLJBIZZNZJV-UHFFFAOYSA-N 4-(3,5-dimethoxyphenyl)sulfonylaniline Chemical compound COC1=CC(OC)=CC(S(=O)(=O)C=2C=CC(N)=CC=2)=C1 SBIYLJBIZZNZJV-UHFFFAOYSA-N 0.000 description 3
- NHYXBMSRKCSGSO-UHFFFAOYSA-N 4-(benzenesulfonyl)-2,6-dibromopyridine Chemical compound BrC1=NC(Br)=CC(S(=O)(=O)C=2C=CC=CC=2)=C1 NHYXBMSRKCSGSO-UHFFFAOYSA-N 0.000 description 3
- NWRWHCVFPFRWQD-UHFFFAOYSA-N 4-(benzenesulfonyl)-6-bromo-n-methylpyridin-2-amine Chemical compound BrC1=NC(NC)=CC(S(=O)(=O)C=2C=CC=CC=2)=C1 NWRWHCVFPFRWQD-UHFFFAOYSA-N 0.000 description 3
- CMTZTVLAIRCQQM-UHFFFAOYSA-N 4-nitrobenzenethiol;potassium Chemical compound [K].[O-][N+](=O)C1=CC=C(S)C=C1 CMTZTVLAIRCQQM-UHFFFAOYSA-N 0.000 description 3
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 229910021595 Copper(I) iodide Inorganic materials 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 3
- 239000010949 copper Substances 0.000 description 3
- LSXDOTMGLUJQCM-UHFFFAOYSA-M copper(i) iodide Chemical compound I[Cu] LSXDOTMGLUJQCM-UHFFFAOYSA-M 0.000 description 3
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 3
- DQYBDCGIPTYXML-UHFFFAOYSA-N ethoxyethane;hydrate Chemical compound O.CCOCC DQYBDCGIPTYXML-UHFFFAOYSA-N 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 239000012065 filter cake Substances 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 239000003446 ligand Substances 0.000 description 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 3
- AXFSCSIPJPWGGF-UHFFFAOYSA-N n-(3-amino-5-bromophenyl)-n-methylacetamide Chemical compound CC(=O)N(C)C1=CC(N)=CC(Br)=C1 AXFSCSIPJPWGGF-UHFFFAOYSA-N 0.000 description 3
- QAODZJHGGBNWJT-UHFFFAOYSA-N n-[3-bromo-5-(4-nitrophenyl)sulfanylphenyl]-n-methylacetamide Chemical compound CC(=O)N(C)C1=CC(Br)=CC(SC=2C=CC(=CC=2)[N+]([O-])=O)=C1 QAODZJHGGBNWJT-UHFFFAOYSA-N 0.000 description 3
- 229920005862 polyol Polymers 0.000 description 3
- 150000003077 polyols Chemical class 0.000 description 3
- 238000001953 recrystallisation Methods 0.000 description 3
- 125000005931 tert-butyloxycarbonyl group Chemical group [H]C([H])([H])C(OC(*)=O)(C([H])([H])[H])C([H])([H])[H] 0.000 description 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 3
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 3
- MGXZELJLJUAEDZ-UHFFFAOYSA-N 1,3-dimethoxy-5-(4-nitrophenyl)sulfanylbenzene Chemical compound COC1=CC(OC)=CC(SC=2C=CC(=CC=2)[N+]([O-])=O)=C1 MGXZELJLJUAEDZ-UHFFFAOYSA-N 0.000 description 2
- YKVYMWIUKFZVOI-UHFFFAOYSA-N 1,3-dimethoxy-5-(4-nitrophenyl)sulfonylbenzene Chemical compound COC1=CC(OC)=CC(S(=O)(=O)C=2C=CC(=CC=2)[N+]([O-])=O)=C1 YKVYMWIUKFZVOI-UHFFFAOYSA-N 0.000 description 2
- OQIWXROVZNCJRX-UHFFFAOYSA-N 1,3-dimethyl-5-(4-nitrophenyl)sulfanylbenzene Chemical compound CC1=CC(C)=CC(SC=2C=CC(=CC=2)[N+]([O-])=O)=C1 OQIWXROVZNCJRX-UHFFFAOYSA-N 0.000 description 2
- DHCFRRZCSDJCMP-UHFFFAOYSA-N 1,3-dimethyl-5-(4-nitrophenyl)sulfonylbenzene Chemical compound CC1=CC(C)=CC(S(=O)(=O)C=2C=CC(=CC=2)[N+]([O-])=O)=C1 DHCFRRZCSDJCMP-UHFFFAOYSA-N 0.000 description 2
- WFQDTOYDVUWQMS-UHFFFAOYSA-N 1-fluoro-4-nitrobenzene Chemical compound [O-][N+](=O)C1=CC=C(F)C=C1 WFQDTOYDVUWQMS-UHFFFAOYSA-N 0.000 description 2
- ZRJOSKZFNRKXMB-UHFFFAOYSA-N 2,6-dibromo-4-[3-(trifluoromethyl)phenyl]sulfanylpyridine Chemical compound FC(F)(F)C1=CC=CC(SC=2C=C(Br)N=C(Br)C=2)=C1 ZRJOSKZFNRKXMB-UHFFFAOYSA-N 0.000 description 2
- RQJDKHKRPWBQLF-UHFFFAOYSA-N 2-(4-aminophenyl)sulfonyl-6-bromopyridin-4-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC(N)=CC(Br)=N1 RQJDKHKRPWBQLF-UHFFFAOYSA-N 0.000 description 2
- RLOAKANOZZJZDS-UHFFFAOYSA-N 2-bromo-6-methyl-4-(4-nitrophenyl)sulfanylpyridine Chemical compound BrC1=NC(C)=CC(SC=2C=CC(=CC=2)[N+]([O-])=O)=C1 RLOAKANOZZJZDS-UHFFFAOYSA-N 0.000 description 2
- BVBRVPXLHHOEMP-UHFFFAOYSA-N 2-bromo-6-methyl-4-nitropyridine Chemical compound CC1=CC([N+]([O-])=O)=CC(Br)=N1 BVBRVPXLHHOEMP-UHFFFAOYSA-N 0.000 description 2
- LWVGONXDPOJHJB-UHFFFAOYSA-N 2-bromo-n-methyl-6-(4-nitrophenyl)sulfonylpyridin-4-amine Chemical compound CNC1=CC(Br)=NC(S(=O)(=O)C=2C=CC(=CC=2)[N+]([O-])=O)=C1 LWVGONXDPOJHJB-UHFFFAOYSA-N 0.000 description 2
- OIJZFMVTAQMMFM-UHFFFAOYSA-N 3-(4-aminophenyl)sulfonyl-n-methylaniline Chemical compound CNC1=CC=CC(S(=O)(=O)C=2C=CC(N)=CC=2)=C1 OIJZFMVTAQMMFM-UHFFFAOYSA-N 0.000 description 2
- WSISKTOPPWWWDB-UHFFFAOYSA-N 3-(benzenesulfonyl)-5-bromo-n-methylaniline Chemical compound CNC1=CC(Br)=CC(S(=O)(=O)C=2C=CC=CC=2)=C1 WSISKTOPPWWWDB-UHFFFAOYSA-N 0.000 description 2
- LODZPNBZAIXVNE-UHFFFAOYSA-N 3-bromo-n,n-dimethyl-5-(4-nitrophenyl)sulfanylaniline Chemical compound CN(C)C1=CC(Br)=CC(SC=2C=CC(=CC=2)[N+]([O-])=O)=C1 LODZPNBZAIXVNE-UHFFFAOYSA-N 0.000 description 2
- BNLMBSZFUWGBIW-UHFFFAOYSA-N 3-bromo-n-ethyl-n-methyl-5-(4-nitrophenyl)sulfanylaniline Chemical compound CCN(C)C1=CC(Br)=CC(SC=2C=CC(=CC=2)[N+]([O-])=O)=C1 BNLMBSZFUWGBIW-UHFFFAOYSA-N 0.000 description 2
- UIKUBYKUYUSRSM-UHFFFAOYSA-N 3-morpholinopropylamine Chemical compound NCCCN1CCOCC1 UIKUBYKUYUSRSM-UHFFFAOYSA-N 0.000 description 2
- LUEYVFJNBLOCSU-UHFFFAOYSA-N 4,6-dibromo-n-methylpyrimidin-2-amine Chemical compound CNC1=NC(Br)=CC(Br)=N1 LUEYVFJNBLOCSU-UHFFFAOYSA-N 0.000 description 2
- CGEPTUWAJHDQTN-UHFFFAOYSA-N 4-(2,6-dichloropyridin-4-yl)sulfonylaniline Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC(Cl)=NC(Cl)=C1 CGEPTUWAJHDQTN-UHFFFAOYSA-N 0.000 description 2
- RHOODANTDMIQNT-UHFFFAOYSA-N 4-(2,6-diiodopyridin-4-yl)sulfanylaniline Chemical compound C1=CC(N)=CC=C1SC1=CC(I)=NC(I)=C1 RHOODANTDMIQNT-UHFFFAOYSA-N 0.000 description 2
- IDFJKWVRDKFEID-UHFFFAOYSA-N 4-(2,6-diiodopyridin-4-yl)sulfonylaniline Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC(I)=NC(I)=C1 IDFJKWVRDKFEID-UHFFFAOYSA-N 0.000 description 2
- MESZMZLIUVVRFY-UHFFFAOYSA-N 4-(2-ethyl-6-pyrrolidin-1-ylpyridin-4-yl)sulfonylaniline Chemical compound N=1C(CC)=CC(S(=O)(=O)C=2C=CC(N)=CC=2)=CC=1N1CCCC1 MESZMZLIUVVRFY-UHFFFAOYSA-N 0.000 description 2
- XQLYFTGVPUJCDJ-UHFFFAOYSA-N 4-(3,5-dimethoxyphenyl)sulfanyl-2-methyl-1-nitrobenzene Chemical compound COC1=CC(OC)=CC(SC=2C=C(C)C(=CC=2)[N+]([O-])=O)=C1 XQLYFTGVPUJCDJ-UHFFFAOYSA-N 0.000 description 2
- GQTQEIMVFWBEKX-UHFFFAOYSA-N 4-(3,5-dimethoxyphenyl)sulfonyl-2-methyl-1-nitrobenzene Chemical compound COC1=CC(OC)=CC(S(=O)(=O)C=2C=C(C)C(=CC=2)[N+]([O-])=O)=C1 GQTQEIMVFWBEKX-UHFFFAOYSA-N 0.000 description 2
- AUXVFTAPQJEIOK-UHFFFAOYSA-N 4-(3,5-dimethoxyphenyl)sulfonyl-2-methylaniline Chemical compound COC1=CC(OC)=CC(S(=O)(=O)C=2C=C(C)C(N)=CC=2)=C1 AUXVFTAPQJEIOK-UHFFFAOYSA-N 0.000 description 2
- VIOXQMKDUIDDOZ-UHFFFAOYSA-N 4-(3,5-dimethylphenyl)sulfonylaniline Chemical compound CC1=CC(C)=CC(S(=O)(=O)C=2C=CC(N)=CC=2)=C1 VIOXQMKDUIDDOZ-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 2
- AUAQIDPQKAZXPQ-UHFFFAOYSA-N 4-(4-aminophenyl)sulfonyl-6-bromopyridin-2-amine Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC(N)=NC(Br)=C1 AUAQIDPQKAZXPQ-UHFFFAOYSA-N 0.000 description 2
- KRWWTMQJRVOKSA-UHFFFAOYSA-N 4-(4-aminophenyl)sulfonyl-6-bromopyridine-2-carbonitrile Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC(Br)=NC(C#N)=C1 KRWWTMQJRVOKSA-UHFFFAOYSA-N 0.000 description 2
- XAKJUJHXFZAUMF-UHFFFAOYSA-N 4-(benzenesulfonyl)-6-bromo-n-methylpyrimidin-2-amine Chemical compound CNC1=NC(Br)=CC(S(=O)(=O)C=2C=CC=CC=2)=N1 XAKJUJHXFZAUMF-UHFFFAOYSA-N 0.000 description 2
- FZKPKEOQFWLSBZ-UHFFFAOYSA-N 4-(benzenesulfonyl)-n-methylpyridin-2-amine Chemical compound C1=NC(NC)=CC(S(=O)(=O)C=2C=CC=CC=2)=C1 FZKPKEOQFWLSBZ-UHFFFAOYSA-N 0.000 description 2
- QVXAZQISIYTVHB-UHFFFAOYSA-N 4-[2-(2-methoxyphenyl)-6-pyrrolidin-1-ylpyridin-4-yl]sulfonylaniline Chemical compound COC1=CC=CC=C1C1=CC(S(=O)(=O)C=2C=CC(N)=CC=2)=CC(N2CCCC2)=N1 QVXAZQISIYTVHB-UHFFFAOYSA-N 0.000 description 2
- UNXOSMKGKQLGHX-UHFFFAOYSA-N 4-bromo-n-methyl-6-(4-nitrophenyl)sulfanylpyrimidin-2-amine Chemical compound CNC1=NC(Br)=CC(SC=2C=CC(=CC=2)[N+]([O-])=O)=N1 UNXOSMKGKQLGHX-UHFFFAOYSA-N 0.000 description 2
- DVUXBGCIUGTUAL-UHFFFAOYSA-N 4-bromo-n-methyl-6-(4-nitrophenyl)sulfonylpyrimidin-2-amine Chemical compound CNC1=NC(Br)=CC(S(=O)(=O)C=2C=CC(=CC=2)[N+]([O-])=O)=N1 DVUXBGCIUGTUAL-UHFFFAOYSA-N 0.000 description 2
- LFCSBHYQMLWJSH-UHFFFAOYSA-N 6-bromo-4-(4-nitrophenyl)sulfanylpyridine-2-carboxamide Chemical compound BrC1=NC(C(=O)N)=CC(SC=2C=CC(=CC=2)[N+]([O-])=O)=C1 LFCSBHYQMLWJSH-UHFFFAOYSA-N 0.000 description 2
- YEXVRGALGLUGLX-UHFFFAOYSA-N 6-bromo-4-(4-nitrophenyl)sulfonylpyridine-2-carbonitrile Chemical compound C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)C1=CC(Br)=NC(C#N)=C1 YEXVRGALGLUGLX-UHFFFAOYSA-N 0.000 description 2
- JYBKXWOVARXFMH-UHFFFAOYSA-N 6-bromo-4-(4-nitrophenyl)sulfonylpyridine-2-carboxamide Chemical compound BrC1=NC(C(=O)N)=CC(S(=O)(=O)C=2C=CC(=CC=2)[N+]([O-])=O)=C1 JYBKXWOVARXFMH-UHFFFAOYSA-N 0.000 description 2
- YOOZMNUTHJSJEA-UHFFFAOYSA-N 6-bromo-4-nitropyridine-2-carboxamide Chemical compound NC(=O)C1=CC([N+]([O-])=O)=CC(Br)=N1 YOOZMNUTHJSJEA-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- YXHKONLOYHBTNS-UHFFFAOYSA-N Diazomethane Chemical compound C=[N+]=[N-] YXHKONLOYHBTNS-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- UEXCJVNBTNXOEH-UHFFFAOYSA-N Ethynylbenzene Chemical group C#CC1=CC=CC=C1 UEXCJVNBTNXOEH-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 2
- 239000007832 Na2SO4 Substances 0.000 description 2
- 102100026450 POU domain, class 3, transcription factor 4 Human genes 0.000 description 2
- 101710133389 POU domain, class 3, transcription factor 4 Proteins 0.000 description 2
- NFHFRUOZVGFOOS-UHFFFAOYSA-N Pd(PPh3)4 Substances [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 NFHFRUOZVGFOOS-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 238000009739 binding Methods 0.000 description 2
- IUNMPGNGSSIWFP-UHFFFAOYSA-N dimethylaminopropylamine Chemical compound CN(C)CCCN IUNMPGNGSSIWFP-UHFFFAOYSA-N 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 239000008298 dragée Substances 0.000 description 2
- 239000003925 fat Substances 0.000 description 2
- 235000013312 flour Nutrition 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 2
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 2
- 238000005984 hydrogenation reaction Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- QOHMWDJIBGVPIF-UHFFFAOYSA-N n',n'-diethylpropane-1,3-diamine Chemical compound CCN(CC)CCCN QOHMWDJIBGVPIF-UHFFFAOYSA-N 0.000 description 2
- DILRJUIACXKSQE-UHFFFAOYSA-N n',n'-dimethylethane-1,2-diamine Chemical compound CN(C)CCN DILRJUIACXKSQE-UHFFFAOYSA-N 0.000 description 2
- RFDUCYPXRSORRE-UHFFFAOYSA-N n'-[4-(4-aminophenyl)sulfonyl-6-bromopyridin-2-yl]-n,n,n'-trimethylethane-1,2-diamine Chemical compound BrC1=NC(N(C)CCN(C)C)=CC(S(=O)(=O)C=2C=CC(N)=CC=2)=C1 RFDUCYPXRSORRE-UHFFFAOYSA-N 0.000 description 2
- QHJABUZHRJTCAR-UHFFFAOYSA-N n'-methylpropane-1,3-diamine Chemical compound CNCCCN QHJABUZHRJTCAR-UHFFFAOYSA-N 0.000 description 2
- HVOYZOQVDYHUPF-UHFFFAOYSA-N n,n',n'-trimethylethane-1,2-diamine Chemical compound CNCCN(C)C HVOYZOQVDYHUPF-UHFFFAOYSA-N 0.000 description 2
- WCRQJANTGYDTIO-UHFFFAOYSA-N n-(3-bromo-5-nitrophenyl)-n-methylacetamide Chemical compound CC(=O)N(C)C1=CC(Br)=CC([N+]([O-])=O)=C1 WCRQJANTGYDTIO-UHFFFAOYSA-N 0.000 description 2
- FPZGWUJXQMMQFD-UHFFFAOYSA-N n-(3-bromo-5-nitrophenyl)acetamide Chemical compound CC(=O)NC1=CC(Br)=CC([N+]([O-])=O)=C1 FPZGWUJXQMMQFD-UHFFFAOYSA-N 0.000 description 2
- DALUMLZPAGVFQC-UHFFFAOYSA-N n-(3-bromo-5-phenylsulfanylphenyl)-n-methylacetamide Chemical compound CC(=O)N(C)C1=CC(Br)=CC(SC=2C=CC=CC=2)=C1 DALUMLZPAGVFQC-UHFFFAOYSA-N 0.000 description 2
- UGUBYMPTLLSWIP-UHFFFAOYSA-N n-[3-(4-aminophenyl)sulfonyl-5-bromophenyl]-n-methylacetamide Chemical compound CC(=O)N(C)C1=CC(Br)=CC(S(=O)(=O)C=2C=CC(N)=CC=2)=C1 UGUBYMPTLLSWIP-UHFFFAOYSA-N 0.000 description 2
- HLVYGPWIXMRQOE-UHFFFAOYSA-N n-[3-(4-aminophenyl)sulfonylphenyl]-n-methylacetamide Chemical compound CC(=O)N(C)C1=CC=CC(S(=O)(=O)C=2C=CC(N)=CC=2)=C1 HLVYGPWIXMRQOE-UHFFFAOYSA-N 0.000 description 2
- DIPQINUIPYUNIT-UHFFFAOYSA-N n-[3-(benzenesulfonyl)-5-bromophenyl]-n-methylacetamide Chemical compound CC(=O)N(C)C1=CC(Br)=CC(S(=O)(=O)C=2C=CC=CC=2)=C1 DIPQINUIPYUNIT-UHFFFAOYSA-N 0.000 description 2
- OJCFBZNPINLIBP-UHFFFAOYSA-N n-[3-(benzenesulfonyldiazenyl)-5-bromophenyl]-n-methylacetamide Chemical compound CC(=O)N(C)C1=CC(Br)=CC(N=NS(=O)(=O)C=2C=CC=CC=2)=C1 OJCFBZNPINLIBP-UHFFFAOYSA-N 0.000 description 2
- IFNFDBJVJCBQRY-UHFFFAOYSA-N n-[3-bromo-5-(4-nitrophenyl)sulfonylphenyl]-n-methylacetamide Chemical compound CC(=O)N(C)C1=CC(Br)=CC(S(=O)(=O)C=2C=CC(=CC=2)[N+]([O-])=O)=C1 IFNFDBJVJCBQRY-UHFFFAOYSA-N 0.000 description 2
- OKEMWIBSXGHHMV-UHFFFAOYSA-N n-[4-(2,6-dibromopyridin-4-yl)sulfonylphenyl]acetamide Chemical compound C1=CC(NC(=O)C)=CC=C1S(=O)(=O)C1=CC(Br)=NC(Br)=C1 OKEMWIBSXGHHMV-UHFFFAOYSA-N 0.000 description 2
- MDGLNFBQLZPXRM-UHFFFAOYSA-N n-methyl-n-[3-(4-nitrophenyl)sulfanylphenyl]acetamide Chemical compound CC(=O)N(C)C1=CC=CC(SC=2C=CC(=CC=2)[N+]([O-])=O)=C1 MDGLNFBQLZPXRM-UHFFFAOYSA-N 0.000 description 2
- JQDDSBHZSDBMQL-UHFFFAOYSA-N n-methyl-n-[3-(4-nitrophenyl)sulfonylphenyl]acetamide Chemical compound CC(=O)N(C)C1=CC=CC(S(=O)(=O)C=2C=CC(=CC=2)[N+]([O-])=O)=C1 JQDDSBHZSDBMQL-UHFFFAOYSA-N 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- HXITXNWTGFUOAU-UHFFFAOYSA-N phenylboronic acid Chemical compound OB(O)C1=CC=CC=C1 HXITXNWTGFUOAU-UHFFFAOYSA-N 0.000 description 2
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- RZWQDAUIUBVCDD-UHFFFAOYSA-M sodium;benzenethiolate Chemical compound [Na+].[S-]C1=CC=CC=C1 RZWQDAUIUBVCDD-UHFFFAOYSA-M 0.000 description 2
- 239000011877 solvent mixture Substances 0.000 description 2
- SRJQTHAZUNRMPR-UYQKXTDMSA-N spinosyn A Chemical compound O([C@H]1CCC[C@@H](OC(=O)C[C@H]2[C@@H]3C=C[C@@H]4C[C@H](C[C@H]4[C@@H]3C=C2C(=O)[C@@H]1C)O[C@H]1[C@@H]([C@H](OC)[C@@H](OC)[C@H](C)O1)OC)CC)[C@H]1CC[C@H](N(C)C)[C@@H](C)O1 SRJQTHAZUNRMPR-UYQKXTDMSA-N 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 2
- QAEDZJGFFMLHHQ-UHFFFAOYSA-N trifluoroacetic anhydride Chemical compound FC(F)(F)C(=O)OC(=O)C(F)(F)F QAEDZJGFFMLHHQ-UHFFFAOYSA-N 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- RRCMGJCFMJBHQC-UHFFFAOYSA-N (2-chlorophenyl)boronic acid Chemical compound OB(O)C1=CC=CC=C1Cl RRCMGJCFMJBHQC-UHFFFAOYSA-N 0.000 description 1
- QCSLIRFWJPOENV-UHFFFAOYSA-N (2-fluorophenyl)boronic acid Chemical compound OB(O)C1=CC=CC=C1F QCSLIRFWJPOENV-UHFFFAOYSA-N 0.000 description 1
- ROEQGIFOWRQYHD-UHFFFAOYSA-N (2-methoxyphenyl)boronic acid Chemical compound COC1=CC=CC=C1B(O)O ROEQGIFOWRQYHD-UHFFFAOYSA-N 0.000 description 1
- SDEAGACSNFSZCU-UHFFFAOYSA-N (3-chlorophenyl)boronic acid Chemical compound OB(O)C1=CC=CC(Cl)=C1 SDEAGACSNFSZCU-UHFFFAOYSA-N 0.000 description 1
- NLLGFYPSWCMUIV-UHFFFAOYSA-N (3-methoxyphenyl)boronic acid Chemical compound COC1=CC=CC(B(O)O)=C1 NLLGFYPSWCMUIV-UHFFFAOYSA-N 0.000 description 1
- CAYQIZIAYYNFCS-UHFFFAOYSA-N (4-chlorophenyl)boronic acid Chemical compound OB(O)C1=CC=C(Cl)C=C1 CAYQIZIAYYNFCS-UHFFFAOYSA-N 0.000 description 1
- VOAAEKKFGLPLLU-UHFFFAOYSA-N (4-methoxyphenyl)boronic acid Chemical compound COC1=CC=C(B(O)O)C=C1 VOAAEKKFGLPLLU-UHFFFAOYSA-N 0.000 description 1
- BIWQNIMLAISTBV-UHFFFAOYSA-N (4-methylphenyl)boronic acid Chemical compound CC1=CC=C(B(O)O)C=C1 BIWQNIMLAISTBV-UHFFFAOYSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- CFTVSWKMBZXAHM-UHFFFAOYSA-N 2-bromo-4-nitro-6-(4-nitrophenyl)sulfanylpyridine Chemical compound C1=CC([N+](=O)[O-])=CC=C1SC1=CC([N+]([O-])=O)=CC(Br)=N1 CFTVSWKMBZXAHM-UHFFFAOYSA-N 0.000 description 1
- VJJPEEGQWXUFTI-UHFFFAOYSA-N 2-bromo-6-methyl-4-(4-nitrophenyl)sulfonylpyridine Chemical compound BrC1=NC(C)=CC(S(=O)(=O)C=2C=CC(=CC=2)[N+]([O-])=O)=C1 VJJPEEGQWXUFTI-UHFFFAOYSA-N 0.000 description 1
- CEBKHWWANWSNTI-UHFFFAOYSA-N 2-methylbut-3-yn-2-ol Chemical compound CC(C)(O)C#C CEBKHWWANWSNTI-UHFFFAOYSA-N 0.000 description 1
- SMJVKNXHRBZLQU-UHFFFAOYSA-N 3,5-dimethylbenzenethiol;potassium Chemical compound [K].CC1=CC(C)=CC(S)=C1 SMJVKNXHRBZLQU-UHFFFAOYSA-N 0.000 description 1
- VBANXLMZDBUBMQ-UHFFFAOYSA-N 3-(4-aminophenyl)sulfonyl-5-bromo-n-ethyl-n-methylaniline Chemical compound CCN(C)C1=CC(Br)=CC(S(=O)(=O)C=2C=CC(N)=CC=2)=C1 VBANXLMZDBUBMQ-UHFFFAOYSA-N 0.000 description 1
- SCURCOWZQJIUGR-UHFFFAOYSA-N 3-(trifluoromethyl)benzenethiol Chemical compound FC(F)(F)C1=CC=CC(S)=C1 SCURCOWZQJIUGR-UHFFFAOYSA-N 0.000 description 1
- GWLFQPJKTXGLGD-UHFFFAOYSA-N 3-bromo-5-nitroaniline Chemical compound NC1=CC(Br)=CC([N+]([O-])=O)=C1 GWLFQPJKTXGLGD-UHFFFAOYSA-N 0.000 description 1
- KQYBJDJNKVPFLU-UHFFFAOYSA-N 3-bromo-n,n-dimethyl-5-(4-nitrophenyl)sulfonylaniline Chemical compound CN(C)C1=CC(Br)=CC(S(=O)(=O)C=2C=CC(=CC=2)[N+]([O-])=O)=C1 KQYBJDJNKVPFLU-UHFFFAOYSA-N 0.000 description 1
- ZNRGSYUVFVNSAW-UHFFFAOYSA-N 3-nitrophenylboronic acid Chemical compound OB(O)C1=CC=CC([N+]([O-])=O)=C1 ZNRGSYUVFVNSAW-UHFFFAOYSA-N 0.000 description 1
- OFBPAUFBRFCTSU-UHFFFAOYSA-N 4-(2-bromo-6-morpholin-4-ylpyridin-4-yl)sulfonylaniline Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC(Br)=NC(N2CCOCC2)=C1 OFBPAUFBRFCTSU-UHFFFAOYSA-N 0.000 description 1
- ZPRMEMDECHAMCA-UHFFFAOYSA-N 4-(2-cyclopropyl-6-pyrrolidin-1-ylpyridin-4-yl)sulfonylaniline Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC(C2CC2)=NC(N2CCCC2)=C1 ZPRMEMDECHAMCA-UHFFFAOYSA-N 0.000 description 1
- MOZAEKIGLZCFBJ-UHFFFAOYSA-N 4-(2-naphthalen-1-yl-6-pyrrolidin-1-ylpyridin-4-yl)sulfonylaniline Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC(N2CCCC2)=NC(C=2C3=CC=CC=C3C=CC=2)=C1 MOZAEKIGLZCFBJ-UHFFFAOYSA-N 0.000 description 1
- MOWWEZSUTKCTQZ-UHFFFAOYSA-N 4-(2-naphthalen-2-yl-6-pyrrolidin-1-ylpyridin-4-yl)sulfonylaniline Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC(N2CCCC2)=NC(C=2C=C3C=CC=CC3=CC=2)=C1 MOWWEZSUTKCTQZ-UHFFFAOYSA-N 0.000 description 1
- LZRNXPWXSCQLLR-UHFFFAOYSA-N 4-(2-propan-2-yl-6-pyrrolidin-1-ylpyridin-4-yl)sulfonylaniline Chemical compound N=1C(C(C)C)=CC(S(=O)(=O)C=2C=CC(N)=CC=2)=CC=1N1CCCC1 LZRNXPWXSCQLLR-UHFFFAOYSA-N 0.000 description 1
- MLLPPPMWNDOVCR-UHFFFAOYSA-N 4-(2-pyrrolidin-1-yl-6-thiophen-3-ylpyridin-4-yl)sulfonylaniline Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC(N2CCCC2)=NC(C2=CSC=C2)=C1 MLLPPPMWNDOVCR-UHFFFAOYSA-N 0.000 description 1
- URCLOBOJFGXARO-UHFFFAOYSA-N 4-(2-pyrrolidin-1-ylpyridin-4-yl)sulfonylaniline Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC=NC(N2CCCC2)=C1 URCLOBOJFGXARO-UHFFFAOYSA-N 0.000 description 1
- DEBNPRMKRXATLA-UHFFFAOYSA-N 4-(4-aminophenyl)sulfonyl-n,6-dimethylpyridin-2-amine Chemical compound CC1=NC(NC)=CC(S(=O)(=O)C=2C=CC(N)=CC=2)=C1 DEBNPRMKRXATLA-UHFFFAOYSA-N 0.000 description 1
- YIZAXUNWVFKLOY-UHFFFAOYSA-N 4-(4-aminophenyl)sulfonyl-n,n,6-trimethylpyridin-2-amine Chemical compound CC1=NC(N(C)C)=CC(S(=O)(=O)C=2C=CC(N)=CC=2)=C1 YIZAXUNWVFKLOY-UHFFFAOYSA-N 0.000 description 1
- PLUOVVVOGFGXFP-UHFFFAOYSA-N 4-(benzenesulfonyl)-6-bromo-n,n-dimethylpyridin-2-amine Chemical compound BrC1=NC(N(C)C)=CC(S(=O)(=O)C=2C=CC=CC=2)=C1 PLUOVVVOGFGXFP-UHFFFAOYSA-N 0.000 description 1
- HZYQGKYNSOODPY-UHFFFAOYSA-N 4-[2-(1-methylcyclopropyl)-6-pyrrolidin-1-ylpyridin-4-yl]sulfonylaniline Chemical compound C=1C(S(=O)(=O)C=2C=CC(N)=CC=2)=CC(N2CCCC2)=NC=1C1(C)CC1 HZYQGKYNSOODPY-UHFFFAOYSA-N 0.000 description 1
- PKHDSCOEXOAUQO-UHFFFAOYSA-N 4-[2-(2-chlorophenyl)-6-pyrrolidin-1-ylpyridin-4-yl]sulfonylaniline Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC(N2CCCC2)=NC(C=2C(=CC=CC=2)Cl)=C1 PKHDSCOEXOAUQO-UHFFFAOYSA-N 0.000 description 1
- HJTOFIQUJOJFOS-UHFFFAOYSA-N 4-[2-(2-fluorophenyl)-6-pyrrolidin-1-ylpyridin-4-yl]sulfonylaniline Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC(N2CCCC2)=NC(C=2C(=CC=CC=2)F)=C1 HJTOFIQUJOJFOS-UHFFFAOYSA-N 0.000 description 1
- WYVMTAPYBNPZCY-UHFFFAOYSA-N 4-[2-(2-phenylethynyl)-6-pyrrolidin-1-ylpyridin-4-yl]sulfonylaniline Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC(C#CC=2C=CC=CC=2)=NC(N2CCCC2)=C1 WYVMTAPYBNPZCY-UHFFFAOYSA-N 0.000 description 1
- XTLSAKXPYNITRU-UHFFFAOYSA-N 4-[2-(3,3-dimethylbut-1-ynyl)-6-pyrrolidin-1-ylpyridin-4-yl]sulfonylaniline Chemical compound N=1C(C#CC(C)(C)C)=CC(S(=O)(=O)C=2C=CC(N)=CC=2)=CC=1N1CCCC1 XTLSAKXPYNITRU-UHFFFAOYSA-N 0.000 description 1
- KJKNLIUZQOFMBA-UHFFFAOYSA-N 4-[2-(3-methoxyphenyl)-6-pyrrolidin-1-ylpyridin-4-yl]sulfonylaniline Chemical compound COC1=CC=CC(C=2N=C(C=C(C=2)S(=O)(=O)C=2C=CC(N)=CC=2)N2CCCC2)=C1 KJKNLIUZQOFMBA-UHFFFAOYSA-N 0.000 description 1
- RJJWAQAUAVPPEQ-UHFFFAOYSA-N 4-[2-(3-nitrophenyl)-6-pyrrolidin-1-ylpyridin-4-yl]sulfonylaniline Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC(N2CCCC2)=NC(C=2C=C(C=CC=2)[N+]([O-])=O)=C1 RJJWAQAUAVPPEQ-UHFFFAOYSA-N 0.000 description 1
- CMCNYXHEMWTIBY-UHFFFAOYSA-N 4-[2-(4-chlorophenyl)-6-pyrrolidin-1-ylpyridin-4-yl]sulfonylaniline Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC(N2CCCC2)=NC(C=2C=CC(Cl)=CC=2)=C1 CMCNYXHEMWTIBY-UHFFFAOYSA-N 0.000 description 1
- XJMXSSPYMPQXFJ-UHFFFAOYSA-N 4-[2-(4-methoxyphenyl)-6-pyrrolidin-1-ylpyridin-4-yl]sulfonylaniline Chemical compound C1=CC(OC)=CC=C1C1=CC(S(=O)(=O)C=2C=CC(N)=CC=2)=CC(N2CCCC2)=N1 XJMXSSPYMPQXFJ-UHFFFAOYSA-N 0.000 description 1
- GFVKDJVXNXAZOZ-UHFFFAOYSA-N 4-[2-(4-methylphenyl)-6-pyrrolidin-1-ylpyridin-4-yl]sulfonylaniline Chemical compound C1=CC(C)=CC=C1C1=CC(S(=O)(=O)C=2C=CC(N)=CC=2)=CC(N2CCCC2)=N1 GFVKDJVXNXAZOZ-UHFFFAOYSA-N 0.000 description 1
- MQOOXTJTVOQQLG-UHFFFAOYSA-N 4-[2-(cyclohexen-1-yl)-6-pyrrolidin-1-ylpyridin-4-yl]sulfonylaniline Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC(N2CCCC2)=NC(C=2CCCCC=2)=C1 MQOOXTJTVOQQLG-UHFFFAOYSA-N 0.000 description 1
- NALRQXARUMGCSV-UHFFFAOYSA-N 4-[2-[3,5-bis(trifluoromethyl)phenyl]-6-pyrrolidin-1-ylpyridin-4-yl]sulfonylaniline Chemical compound C1=CC(N)=CC=C1S(=O)(=O)C1=CC(N2CCCC2)=NC(C=2C=C(C=C(C=2)C(F)(F)F)C(F)(F)F)=C1 NALRQXARUMGCSV-UHFFFAOYSA-N 0.000 description 1
- LERHVEVOABGWSK-UHFFFAOYSA-N 4-[4-(4-aminophenyl)sulfonyl-6-pyrrolidin-1-ylpyridin-2-yl]-2-methylbut-3-yn-2-ol Chemical compound N=1C(C#CC(C)(O)C)=CC(S(=O)(=O)C=2C=CC(N)=CC=2)=CC=1N1CCCC1 LERHVEVOABGWSK-UHFFFAOYSA-N 0.000 description 1
- QGMJBZYLLFMZQJ-UHFFFAOYSA-N 4-bromo-n-methyl-6-phenylsulfanylpyrimidin-2-amine Chemical compound CNC1=NC(Br)=CC(SC=2C=CC=CC=2)=N1 QGMJBZYLLFMZQJ-UHFFFAOYSA-N 0.000 description 1
- JHFOWEGCZWLHNW-UHFFFAOYSA-N 4-fluoro-2-methyl-1-nitrobenzene Chemical compound CC1=CC(F)=CC=C1[N+]([O-])=O JHFOWEGCZWLHNW-UHFFFAOYSA-N 0.000 description 1
- LBUNNMJLXWQQBY-UHFFFAOYSA-N 4-fluorophenylboronic acid Chemical compound OB(O)C1=CC=C(F)C=C1 LBUNNMJLXWQQBY-UHFFFAOYSA-N 0.000 description 1
- YQBRMUXRAFVSPK-UHFFFAOYSA-N 6-bromo-4-nitropyridine-2-carboxylic acid Chemical compound OC(=O)C1=CC([N+]([O-])=O)=CC(Br)=N1 YQBRMUXRAFVSPK-UHFFFAOYSA-N 0.000 description 1
- FVVJBYQWYQOJJZ-UHFFFAOYSA-N 6-bromo-n-methyl-4-[3-(trifluoromethyl)phenyl]sulfonylpyridin-2-amine Chemical compound BrC1=NC(NC)=CC(S(=O)(=O)C=2C=C(C=CC=2)C(F)(F)F)=C1 FVVJBYQWYQOJJZ-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- PAYRUJLWNCNPSJ-UHFFFAOYSA-N Aniline Chemical compound NC1=CC=CC=C1 PAYRUJLWNCNPSJ-UHFFFAOYSA-N 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 101000933374 Gallus gallus Brain-specific homeobox/POU domain protein 3 Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- MZRVEZGGRBJDDB-UHFFFAOYSA-N N-Butyllithium Chemical compound [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- DPWPWRLQFGFJFI-UHFFFAOYSA-N Pargyline Chemical compound C#CCN(C)CC1=CC=CC=C1 DPWPWRLQFGFJFI-UHFFFAOYSA-N 0.000 description 1
- OFOBLEOULBTSOW-UHFFFAOYSA-N Propanedioic acid Natural products OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- HFKJQIJFRMRSKM-UHFFFAOYSA-N [3,5-bis(trifluoromethyl)phenoxy]boronic acid Chemical compound OB(O)OC1=CC(C(F)(F)F)=CC(C(F)(F)F)=C1 HFKJQIJFRMRSKM-UHFFFAOYSA-N 0.000 description 1
- WOAORAPRPVIATR-UHFFFAOYSA-N [3-(trifluoromethyl)phenyl]boronic acid Chemical compound OB(O)C1=CC=CC(C(F)(F)F)=C1 WOAORAPRPVIATR-UHFFFAOYSA-N 0.000 description 1
- IKHGUXGNUITLKF-XPULMUKRSA-N acetaldehyde Chemical compound [14CH]([14CH3])=O IKHGUXGNUITLKF-XPULMUKRSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 238000005576 amination reaction Methods 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- CBHOOMGKXCMKIR-UHFFFAOYSA-N azane;methanol Chemical class N.OC CBHOOMGKXCMKIR-UHFFFAOYSA-N 0.000 description 1
- 150000007514 bases Chemical class 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 244000309464 bull Species 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 description 1
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003638 chemical reducing agent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 150000004985 diamines Chemical class 0.000 description 1
- 125000001664 diethylamino group Chemical group [H]C([H])([H])C([H])([H])N(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 238000010494 dissociation reaction Methods 0.000 description 1
- 230000005593 dissociations Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000000031 ethylamino group Chemical group [H]C([H])([H])C([H])([H])N([H])[*] 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 230000004992 fission Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 150000007529 inorganic bases Chemical class 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- VZCYOOQTPOCHFL-UPHRSURJSA-N maleic acid Chemical compound OC(=O)\C=C/C(O)=O VZCYOOQTPOCHFL-UPHRSURJSA-N 0.000 description 1
- 239000011976 maleic acid Substances 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 238000001819 mass spectrum Methods 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- 125000000250 methylamino group Chemical group [H]N(*)C([H])([H])[H] 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- HUMMCEUVDBVXTQ-UHFFFAOYSA-N naphthalen-1-ylboronic acid Chemical compound C1=CC=C2C(B(O)O)=CC=CC2=C1 HUMMCEUVDBVXTQ-UHFFFAOYSA-N 0.000 description 1
- KPTRDYONBVUWPD-UHFFFAOYSA-N naphthalen-2-ylboronic acid Chemical compound C1=CC=CC2=CC(B(O)O)=CC=C21 KPTRDYONBVUWPD-UHFFFAOYSA-N 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 239000007800 oxidant agent Substances 0.000 description 1
- YJVFFLUZDVXJQI-UHFFFAOYSA-L palladium(ii) acetate Chemical compound [Pd+2].CC([O-])=O.CC([O-])=O YJVFFLUZDVXJQI-UHFFFAOYSA-L 0.000 description 1
- QJPQVXSHYBGQGM-UHFFFAOYSA-N palladium;triphenylphosphane Chemical compound [Pd].C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1.C1=CC=CC=C1P(C=1C=CC=CC=1)C1=CC=CC=C1 QJPQVXSHYBGQGM-UHFFFAOYSA-N 0.000 description 1
- 229960001779 pargyline Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- 239000012256 powdered iron Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- HUBMBNGODLWSPA-UHFFFAOYSA-N prop-1-en-2-yloxyboronic acid Chemical compound CC(=C)OB(O)O HUBMBNGODLWSPA-UHFFFAOYSA-N 0.000 description 1
- 239000008213 purified water Substances 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- CPCFZBOTLAEGND-UHFFFAOYSA-M sodium;4-acetamidobenzenesulfinate Chemical compound [Na+].CC(=O)NC1=CC=C(S([O-])=O)C=C1 CPCFZBOTLAEGND-UHFFFAOYSA-M 0.000 description 1
- UOOVFPYJUPSROO-UHFFFAOYSA-M sodium;naphthalene-1-sulfinate Chemical compound [Na+].C1=CC=C2C(S(=O)[O-])=CC=CC2=C1 UOOVFPYJUPSROO-UHFFFAOYSA-M 0.000 description 1
- JGGFVSGYTHUAOQ-UHFFFAOYSA-M sodium;naphthalene-2-sulfinate Chemical compound [Na+].C1=CC=CC2=CC(S(=O)[O-])=CC=C21 JGGFVSGYTHUAOQ-UHFFFAOYSA-M 0.000 description 1
- 238000004611 spectroscopical analysis Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical compound OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 230000005062 synaptic transmission Effects 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- ZFQWJXFJJZUVPI-UHFFFAOYSA-N tert-butyl n-(4-aminobutyl)carbamate Chemical compound CC(C)(C)OC(=O)NCCCCN ZFQWJXFJJZUVPI-UHFFFAOYSA-N 0.000 description 1
- OYCYZDFIPYJLDG-UHFFFAOYSA-N tert-butyl n-[4-[[4-(4-aminophenyl)sulfonyl-6-bromopyridin-2-yl]amino]butyl]carbamate Chemical compound BrC1=NC(NCCCCNC(=O)OC(C)(C)C)=CC(S(=O)(=O)C=2C=CC(N)=CC=2)=C1 OYCYZDFIPYJLDG-UHFFFAOYSA-N 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- OBYRCTCRALMZKW-UHFFFAOYSA-N tributyl(cyclohexen-1-yl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C1=CCCCC1 OBYRCTCRALMZKW-UHFFFAOYSA-N 0.000 description 1
- QIWRFOJWQSSRJZ-UHFFFAOYSA-N tributyl(ethenyl)stannane Chemical compound CCCC[Sn](CCCC)(CCCC)C=C QIWRFOJWQSSRJZ-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C317/00—Sulfones; Sulfoxides
- C07C317/26—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton
- C07C317/32—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
- C07C317/34—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring
- C07C317/36—Sulfones; Sulfoxides having sulfone or sulfoxide groups and nitrogen atoms, not being part of nitro or nitroso groups, bound to the same carbon skeleton with sulfone or sulfoxide groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton having sulfone or sulfoxide groups and amino groups bound to carbon atoms of six-membered aromatic rings being part of the same non-condensed ring or of a condensed ring system containing that ring with the nitrogen atoms of the amino groups bound to hydrogen atoms or to carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/62—Oxygen or sulfur atoms
- C07D213/70—Sulfur atoms
- C07D213/71—Sulfur atoms to which a second hetero atom is attached
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/84—Nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/38—One sulfur atom
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Compositions Of Macromolecular Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98100690 | 1998-01-16 |
Publications (3)
Publication Number | Publication Date |
---|---|
NO990187D0 NO990187D0 (no) | 1999-01-15 |
NO990187L NO990187L (no) | 1999-07-19 |
NO312065B1 true NO312065B1 (no) | 2002-03-11 |
Family
ID=8231273
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19990187A NO312065B1 (no) | 1998-01-16 | 1999-01-15 | Benzosulfon-derivater, anvendelse og fremgangsmåte for fremstilling derav, samt medikament |
Country Status (34)
Country | Link |
---|---|
US (1) | US5990105A (fr) |
EP (1) | EP0930302B1 (fr) |
JP (1) | JP3249092B2 (fr) |
KR (1) | KR100319250B1 (fr) |
CN (1) | CN1148356C (fr) |
AR (1) | AR014313A1 (fr) |
AT (1) | ATE236136T1 (fr) |
AU (1) | AU757841B2 (fr) |
BR (1) | BR9900065A (fr) |
CA (1) | CA2258454A1 (fr) |
CO (1) | CO5090847A1 (fr) |
CZ (1) | CZ12099A3 (fr) |
DE (1) | DE69906397T2 (fr) |
DK (1) | DK0930302T3 (fr) |
ES (1) | ES2193607T3 (fr) |
HK (1) | HK1022310A1 (fr) |
HR (1) | HRP990011B1 (fr) |
HU (1) | HUP9900120A3 (fr) |
ID (1) | ID23234A (fr) |
IL (1) | IL128027A (fr) |
MA (1) | MA26599A1 (fr) |
MY (1) | MY121778A (fr) |
NO (1) | NO312065B1 (fr) |
NZ (1) | NZ333706A (fr) |
PE (1) | PE20000170A1 (fr) |
PL (1) | PL194735B1 (fr) |
PT (1) | PT930302E (fr) |
RU (1) | RU2201922C2 (fr) |
SG (1) | SG71898A1 (fr) |
SI (1) | SI0930302T1 (fr) |
TR (1) | TR199900090A3 (fr) |
TW (1) | TW553938B (fr) |
YU (1) | YU1199A (fr) |
ZA (1) | ZA99254B (fr) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7030109B2 (en) | 1999-07-19 | 2006-04-18 | Pharmacia & Upjohn Company | 1,2,3,4,5,6-Hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position |
MY122278A (en) | 1999-07-19 | 2006-04-29 | Upjohn Co | 1,2,3,4,5,6-hexahydroazepino[4,5-b]indoles containing arylsulfones at the 9-position |
DE19956791A1 (de) | 1999-11-25 | 2001-05-31 | Merck Patent Gmbh | Neue Sulfonyloxazolamine |
US7034029B2 (en) | 2000-11-02 | 2006-04-25 | Wyeth | 1-aryl- or 1-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-6 ligands |
PL213134B1 (pl) * | 2000-11-02 | 2013-01-31 | Wyeth Corp | 1-arylo- lub 1-alkilosulfonylo- heterocyklilobenzazole, ich zastosowanie oraz kompozycja farmaceutyczna zawierajaca te zwiazki |
ATE417838T1 (de) | 2001-08-10 | 2009-01-15 | Hoffmann La Roche | Arylsulfonyl-derivate mit 5-ht 6-rezeptor- affinität |
US6727274B2 (en) | 2001-10-09 | 2004-04-27 | Pharmacia & Upjohn Company | Arylsulphonyl substituted-tetrahydro- and hexahydro-carbazoles |
NZ535239A (en) * | 2002-03-27 | 2008-03-28 | Glaxo Group Ltd | Quinoline derivatives and their use as 5-HT6 ligands |
US6875771B2 (en) | 2002-07-26 | 2005-04-05 | Bristol-Myers Squibb Company | Pyridopyrimidine derivatives as 5-HT6 antagonists |
KR101052482B1 (ko) * | 2002-11-21 | 2011-07-28 | 노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 | 포스포티딜이노시톨(pi) 3-키나제 억제제인 2,4,6-삼치환피리미딘 및 암의 치료에서 이들의 사용 |
GB0305575D0 (en) | 2003-03-11 | 2003-04-16 | Glaxo Group Ltd | Novel compounds |
GB0419192D0 (en) * | 2004-08-27 | 2004-09-29 | Merck Sharp & Dohme | Therapeutic agents |
MX2007007558A (es) * | 2004-12-21 | 2007-07-24 | Hoffmann La Roche | Derivados de tetralina y de indano y usos de los mismos. |
WO2006119390A1 (fr) * | 2005-05-04 | 2006-11-09 | Vertex Pharmaceuticals Incorporated | Pyridines utiles en tant que modulateurs de canaux ioniques |
JO2660B1 (en) | 2006-01-20 | 2012-06-17 | نوفارتيس ايه جي | Pi-3 inhibitors and methods of use |
BR122020011899B1 (pt) | 2006-06-16 | 2021-05-11 | H. Lundbeck A/S | processos para a preparação de 1-[2-(2,4-dimetil-fenilsulfanil)-fenil]-piperazina e para a fabricação do sal de adição de ácido bromídrico correspondente |
ES2358549T3 (es) * | 2006-11-09 | 2011-05-11 | F. Hoffmann-La Roche Ag | Arilsulfonil, pirrolidinas como inhibidores de 5-ht6. |
CN101711241A (zh) * | 2007-02-06 | 2010-05-19 | 诺瓦提斯公司 | Pi3-激酶抑制剂和它们的使用方法 |
NZ585374A (en) * | 2007-10-26 | 2011-09-30 | Suven Life Sciences Ltd | Amino arylsulfonamide compounds for treating disorders related to 5-HT6 receptor functions |
WO2009128058A1 (fr) | 2008-04-18 | 2009-10-22 | UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN et al | Produits psycho-pharmaceutiques |
UA100192C2 (en) | 2008-11-11 | 2012-11-26 | УАЙТ ЭлЭлСи | 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands |
RU2443697C1 (ru) | 2010-12-21 | 2012-02-27 | Александр Васильевич Иващенко | Замещенные метил-амины, антагонисты серотониновых 5-ht6 рецепторов, способы получения и применения |
KR20140069235A (ko) | 2011-09-27 | 2014-06-09 | 노파르티스 아게 | 돌연변이체 idh의 억제제로서의 3-피리미딘-4-일-옥사졸리딘-2-온 |
UY34632A (es) | 2012-02-24 | 2013-05-31 | Novartis Ag | Compuestos de oxazolidin- 2- ona y usos de los mismos |
US9296733B2 (en) | 2012-11-12 | 2016-03-29 | Novartis Ag | Oxazolidin-2-one-pyrimidine derivative and use thereof for the treatment of conditions, diseases and disorders dependent upon PI3 kinases |
US10245249B2 (en) | 2013-01-18 | 2019-04-02 | Cardioxyl Pharmaceuticals, Inc. | Pharmaceutical compositions comprising nitroxyl donors |
SG11201507063YA (en) | 2013-03-14 | 2015-10-29 | Novartis Ag | 3-pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant idh |
WO2015090233A1 (fr) | 2013-12-20 | 2015-06-25 | Sunshine Lake Pharma Co., Ltd. | Composés hétérocycliques aromatiques et leur utilisation dans les produits pharmaceutiques |
GB201514021D0 (en) | 2015-08-07 | 2015-09-23 | Arner Elias Set Jeno | Novel Pyridines and their use in the treatment of cancer |
KR20190115013A (ko) | 2017-02-07 | 2019-10-10 | 오블리크 세러퓨틱스 에이비 | 헤테로아릴설포닐-치환된 피리딘 및 암의 치료에서 이의 용도 |
US11161815B2 (en) | 2017-02-07 | 2021-11-02 | Oblique Therapeutics Ab | Hydrocarbylsulfonyl-substituted pyridines and their use in the treatment of cancer |
US11168069B2 (en) | 2017-02-07 | 2021-11-09 | Oblique Therapeutics Ab | Heterocyclylsulfonyl-substituted pyridines and their use in the treatment of cancer |
AU2018218518B2 (en) | 2017-02-07 | 2022-03-17 | Oblique Therapeutics Ab | Sulfinylpyridines and their use in the treatment of cancer |
MA54133B1 (fr) | 2018-03-08 | 2022-01-31 | Incyte Corp | Composés d'aminopyrazine diol utilisés comme inhibiteurs de pi3k-y |
US11046658B2 (en) | 2018-07-02 | 2021-06-29 | Incyte Corporation | Aminopyrazine derivatives as PI3K-γ inhibitors |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS55151560A (en) * | 1979-05-14 | 1980-11-26 | Ishihara Sangyo Kaisha Ltd | Pyridylthioaniline compound |
JPS60185764A (ja) * | 1984-03-05 | 1985-09-21 | Wako Pure Chem Ind Ltd | ピリジン誘導体の新規な製造法 |
WO1992009576A1 (fr) * | 1990-11-27 | 1992-06-11 | MERCK Patent Gesellschaft mit beschränkter Haftung | 2-pyridines d'halogenes 3,6-disubstituees |
GB9214120D0 (en) * | 1991-07-25 | 1992-08-12 | Ici Plc | Therapeutic amides |
JPH06127956A (ja) * | 1992-10-16 | 1994-05-10 | Copal Co Ltd | ガラスレンズの成形装置 |
JP3907722B2 (ja) * | 1995-08-23 | 2007-04-18 | 株式会社クラレ | 2−ヒドロキシピリジン類および/または2(1h)−ピリドン類の製造法 |
JP3907721B2 (ja) * | 1995-08-23 | 2007-04-18 | 株式会社クラレ | 2−アラルキルオキシピリジン類の製造法 |
WO1997036878A1 (fr) * | 1996-03-29 | 1997-10-09 | Ube Industries, Ltd. | Composes de pyrimidine, procede de production de ces composes et bactericides pour l'agriculture et l'horticulture |
JP3814885B2 (ja) * | 1996-09-03 | 2006-08-30 | 宇部興産株式会社 | 2−シアノピリミジン誘導体、その製造法及び農園芸用の殺菌剤 |
US6191280B1 (en) * | 1997-05-30 | 2001-02-20 | Basf Aktiengesellschaft | Method for producing substituted thiopyridines |
KR100396431B1 (ko) * | 1998-01-26 | 2003-09-02 | 가부시키가이샤 구라레 | 2-술포닐피리딘 유도체 및 2-[((2-피리딜)메틸)티오]-1h-벤즈이 |
-
1999
- 1999-01-08 EP EP99100149A patent/EP0930302B1/fr not_active Expired - Lifetime
- 1999-01-08 SI SI9930252T patent/SI0930302T1/xx unknown
- 1999-01-08 ES ES99100149T patent/ES2193607T3/es not_active Expired - Lifetime
- 1999-01-08 PT PT99100149T patent/PT930302E/pt unknown
- 1999-01-08 DK DK99100149T patent/DK0930302T3/da active
- 1999-01-08 DE DE69906397T patent/DE69906397T2/de not_active Expired - Fee Related
- 1999-01-08 AT AT99100149T patent/ATE236136T1/de not_active IP Right Cessation
- 1999-01-12 NZ NZ333706A patent/NZ333706A/xx unknown
- 1999-01-12 PE PE1999000027A patent/PE20000170A1/es not_active Application Discontinuation
- 1999-01-13 HR HR98100690.1 patent/HRP990011B1/xx not_active IP Right Cessation
- 1999-01-13 IL IL12802799A patent/IL128027A/en unknown
- 1999-01-13 YU YU1199A patent/YU1199A/sh unknown
- 1999-01-13 SG SG1999000077A patent/SG71898A1/en unknown
- 1999-01-13 CA CA002258454A patent/CA2258454A1/fr not_active Abandoned
- 1999-01-13 KR KR1019990000667A patent/KR100319250B1/ko not_active IP Right Cessation
- 1999-01-13 TW TW088100465A patent/TW553938B/zh not_active IP Right Cessation
- 1999-01-14 PL PL330841A patent/PL194735B1/pl not_active IP Right Cessation
- 1999-01-14 ZA ZA9900254A patent/ZA99254B/xx unknown
- 1999-01-14 JP JP00741099A patent/JP3249092B2/ja not_active Expired - Fee Related
- 1999-01-14 MY MYPI99000139A patent/MY121778A/en unknown
- 1999-01-14 BR BR9900065-2A patent/BR9900065A/pt not_active Application Discontinuation
- 1999-01-14 CO CO99001735A patent/CO5090847A1/es unknown
- 1999-01-14 TR TR1999/00090A patent/TR199900090A3/tr unknown
- 1999-01-14 CZ CZ99120A patent/CZ12099A3/cs unknown
- 1999-01-15 AR ARP990100132A patent/AR014313A1/es unknown
- 1999-01-15 NO NO19990187A patent/NO312065B1/no unknown
- 1999-01-15 MA MA25434A patent/MA26599A1/fr unknown
- 1999-01-15 AU AU12110/99A patent/AU757841B2/en not_active Ceased
- 1999-01-15 US US09/232,775 patent/US5990105A/en not_active Expired - Fee Related
- 1999-01-15 CN CNB99100955XA patent/CN1148356C/zh not_active Expired - Fee Related
- 1999-01-15 ID IDP990038D patent/ID23234A/id unknown
- 1999-01-15 HU HU9900120A patent/HUP9900120A3/hu unknown
- 1999-01-15 RU RU99101350/04A patent/RU2201922C2/ru not_active IP Right Cessation
-
2000
- 2000-02-28 HK HK00101191A patent/HK1022310A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO312065B1 (no) | Benzosulfon-derivater, anvendelse og fremgangsmåte for fremstilling derav, samt medikament | |
US5998665A (en) | Use of sulfonamides | |
CA2559733C (fr) | Inhibiteurs d'histone desacetylase | |
AU682026B2 (en) | New 4-aminopyridines, process for preparing the same and medicaments containing the same | |
CA2791680A1 (fr) | Composes et utilisations therapeutiques associees | |
JP5247681B2 (ja) | 細胞周期キナーゼの阻害剤としての2,4−ジアミノピリミジン | |
AU2010257504B2 (en) | Pyridinyl derivatives as inhibitors of enzyme nicotinamide phosphoribosyltransferase | |
CA2422013A1 (fr) | Antagonistes du recepteur y.y5 de neuropeptide d'urease substitue | |
WO2005007621A2 (fr) | Inhibiteurs de ligase d'ubiquitine | |
JP2005530763A (ja) | カリウム・チャネル調節物質としてのビス−ベンズイミダゾール及び関連化合物 | |
JP2010513406A (ja) | 癌治療のための細胞周期キナーゼ阻害剤としての2−[(フェニルアミノ)−ピリミジン−4−イルアミノ]−シクロペンタンカルボキサミド誘導体及び関連化合物 | |
MX2007014263A (es) | Nuevos derivados de cromano o tetrahidronaftaleno 8-sulfonil-3-aminosustituidos que modulan al receptor de 5-hidroxi-triptamina 6. | |
PL175788B1 (pl) | Amidowe pochodne indolu i zawierające je kompozycje farmaceutyczne | |
CA2786999A1 (fr) | Composes et procedes | |
TW200540161A (en) | 4-Amino-5-cyanopyrimidine derivatives | |
FI67220B (fi) | Foerfarande foer framstaellning av antitrombotiskt verkande 2-perhydro-1,4-diazino)-pyrimido(5,4-d)pyrimidiner | |
CA3158288A1 (fr) | Composes heteroaryle et leurs utilisations therapeutiques dans des conditions associees a l'alteration de l'activite de la beta-glucocerebrosidase | |
NZ585087A (en) | Benzenesulfonanilide compounds suitable for treating disorders that respond to modulation of the serotonin 5-ht6 receptor | |
Raux | Synthesis of Selective 5-HT6 and 5-HT7 Receptor Antagonists |